Price movement over the last 24 hours
ARK Genomic Revolution ETF vs Global X Defense Tech ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Global X Defense Tech ETF trades at $61.38. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Global X Defense Tech ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | SHLD | |
|---|---|---|
Sector | Sector/Thematic | Sector/Thematic |
52-Week High | $43.57 | $78.02 |
52-Week Low | $23.09 | $58.20 |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
SHLD, the Global X Defense Tech ETF, trades at $61.19, down 0.44% on the day, with technical indicators showing a bearish trend. The ETF provides diversified exposure to global defense technology companies, benefiting from rising military spending worldwide. Recent news highlights focus on defense sector growth, with articles discussing the UK's $20 billion military overhaul and ongoing geopolitical tensions driving demand.
The outlook for SHLD is supported by structural increases in global defense budgets, but faces risks from political shifts and valuation concerns. Analyst sentiment is mixed, with some seeing a rebound opportunity from current levels, while technical weakness suggests near-term caution. The ETF's performance will hinge on sustained government spending and sector earnings growth.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →SHLD tracks the Global X Defense Tech Index, targeting companies that lead the technological transformation of the defense sector. It focuses on pure-play innovators in cybersecurity, artificial intelligence, robotics, and advanced military systems, excluding traditional commercial aerospace to maintain a high level of thematic purity.
Read more on SHLD →